Literature DB >> 20562191

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Marjorie L McCullough1, Stephanie J Weinstein, D Michal Freedman, Kathy Helzlsouer, W Dana Flanders, Karen Koenig, Laurence Kolonel, Francine Laden, Loic Le Marchand, Mark Purdue, Kirk Snyder, Victoria L Stevens, Rachael Stolzenberg-Solomon, Jarmo Virtamo, Gong Yang, Kai Yu, Wei Zheng, Demetrius Albanes, Jason Ashby, Kimberly Bertrand, Hui Cai, Yu Chen, Lisa Gallicchio, Edward Giovannucci, Eric J Jacobs, Susan E Hankinson, Patricia Hartge, Virginia Hartmuller, Chinonye Harvey, Richard B Hayes, Ronald L Horst, Xiao-Ou Shu.   

Abstract

Low vitamin D status is common globally and is associated with multiple disease outcomes. Understanding the correlates of vitamin D status will help guide clinical practice, research, and interpretation of studies. Correlates of circulating 25-hydroxyvitamin D (25(OH)D) concentrations measured in a single laboratory were examined in 4,723 cancer-free men and women from 10 cohorts participating in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, which covers a worldwide geographic area. Demographic and lifestyle characteristics were examined in relation to 25(OH)D using stepwise linear regression and polytomous logistic regression. The prevalence of 25(OH)D concentrations less than 25 nmol/L ranged from 3% to 36% across cohorts, and the prevalence of 25(OH)D concentrations less than 50 nmol/L ranged from 29% to 82%. Seasonal differences in circulating 25(OH)D were most marked among whites from northern latitudes. Statistically significant positive correlates of 25(OH)D included male sex, summer blood draw, vigorous physical activity, vitamin D intake, fish intake, multivitamin use, and calcium supplement use. Significant inverse correlates were body mass index, winter and spring blood draw, history of diabetes, sedentary behavior, smoking, and black race/ethnicity. Correlates varied somewhat within season, race/ethnicity, and sex. These findings help identify persons at risk for low vitamin D status for both clinical and research purposes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562191      PMCID: PMC2892536          DOI: 10.1093/aje/kwq113

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


Vitamin D has established benefits for bone health and may play a preventive role in other major diseases (1), but questions persist about what constitutes optimal vitamin D status. Substantial segments of the population in the United States and globally have low vitamin D concentrations (2). Thus, it is important to understand what factors contribute to concentrations of 25-hydroxyvitamin D (25(OH)D), the major circulating metabolite of vitamin D and indicator of vitamin D status. The major sources of circulating 25(OH)D include exposure to ultraviolet radiation (ultraviolet B, 280–315 nm) and dietary and supplemental vitamin D intake. Additional constitutional and behavioral factors can further influence 25(OH)D status in various populations. Investigators in multiple studies have used statistical modeling to examine the relative contribution of endogenous and exogenous factors to variation in circulating 25(OH)D levels (2–26), and results from many of these studies were summarized in a 2008 International Agency for Research on Cancer report on vitamin D and cancer (27). Many studies were either small and/or lacked diversity by geographic location, age, sex, or race/ethnicity, precluding examination of a broad range of determinants according to specific subpopulations such as race/ethnicity and season of blood collection. For example, approximately half of the studies involved European countries at latitudes greater than or equal to 50°N, which is further north than anywhere in the continental United States (2–5, 8–9, 12–16, 24, 26). In this report, we examine the correlates of circulating 25(OH)D in the large control population of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP). This is a geographically and demographically diverse group of men and women, including participants from US, Finnish, and Chinese cohort studies, with information on numerous factors affecting vitamin D status.

MATERIALS AND METHODS

Study design and population

Study subjects included 4,723 control participants (2,588 female and 2,135 male) from the VDPP (28). Briefly, investigators in the VDPP assayed serum or plasma samples collected prospectively in 1974–2006 for 25(OH)D and examined its association with 6 cancers (endometrial, gastric/esophageal, kidney, ovarian, pancreatic, and non-Hodgkin lymphoma), using a matched nested case-control design (28). The cohorts included in the present analysis were the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC), the Cancer Prevention Study II Nutrition Cohort (CPS-II), CLUE II (named for the slogan “Give us a Clue to Cancer and Heart Disease”), the Health Professionals Follow-up Study (HPFS), the Multiethnic Cohort Study (MEC), the New York University Women's Health Study (NYU-WHS), the Nurses’ Health Study (NHS), the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO), the Shanghai Men's Health Study (SMHS), and the Shanghai Women's Health Study (SWHS). Investigators in each cohort study received institutional review board approval from their home institution(s) to participate in the VDPP.

Measurement of circulating 25(OH)D

All plasma/serum samples were measured for 25(OH)D at Heartland Assays, Inc. (Ames, Iowa), using the DiaSorin LIAISON 25(OH) Vitamin D TOTAL Assay (29) as described in detail elsewhere (28). Batches were analyzed by cohort and included masked vitamin D standards provided by the National Institute of Standards and Technology. Interbatch coefficients of variation for these standards were 12.7% and 13.6% for level 1 (∼60 nmol/L) and level 2 (∼35 nmol/L) standards, respectively (28).

Correlates

Covariate data obtained closest to the time of blood draw in each cohort were cleaned and harmonized. The following potential correlates of circulating 25(OH)D were examined: alcohol use (current use, no current use, or missing data); body mass index (weight (kg)/height (m)2), both continuous and categorical (<25, 25–<30, ≥30, or missing data); education (less than high school, completion of high school, vocational school, some college, college graduation, or graduate study); postmenopausal hormone replacement therapy (no current use, current use, or missing data); history of diabetes (no, yes, or missing data); history of high blood pressure (no, yes, or missing data); physical activity (sedentary, light activity, moderate activity, vigorous activity, or missing data); race/ethnicity (white, black, Asian, other, or missing data); smoking status (never smoker, former smoker, or current smoker); and season of blood draw (winter (January–March), spring (April–June), summer (July–September), or fall (October–December)). Potential dietary determinants of 25(OH)D concentration included vitamin D intake (IU/day, continuous), calcium intake (mg/day, continuous), milk intake (g/day, continuous), dairy food intake (g/day, continuous), fish intake (g/day, continuous), use of calcium supplements (no current use, current use, or missing data), and use of multivitamin supplements (no current use, current use, or missing data). Nutrient levels were energy-adjusted using the residuals method (30). Information on use of individual vitamin D supplements (apart from multivitamin supplements) was not available; however, the prevalence of use of vitamin D-specific supplements was less than 2% among ambulatory US adults in the 1990s (31). Subanalyses were conducted among 4 cohorts for which investigators quantified doses of total vitamin D (dietary intake plus supplemental vitamin D, continuous) and total calcium (dietary intake plus supplemental calcium, continuous) and among 5 cohorts for which there was detailed information on eye color (blue, green/gray, brown/black, or missing data) and hair color (red, blond/light brown, brown/black, or missing data). Information on skin tone was available for only 2 cohorts, so this was not examined.

Statistical analysis

The differences in circulating 25(OH)D were examined by season, stratified by race/ethnicity and, where possible, latitude of residence. Analysis of variance was used to test whether the mean 25(OH)D concentration within season of blood draw varied by latitude (<35°N, 35°N –42°N, or >42°N) or across seasons within each racial/ethnic and latitude group. Participant characteristics were determined according to the following 25(OH)D cutpoints: <25, 25–<37.5, 37.5–<50, 50–<75, 75–<100, and ≥100 nmol/L, corresponding to common cutpoints used in the literature and in the VDPP site-specific analyses (28, 32–34). Stepwise linear regression analysis was used to derive regression coefficients of correlates with continuous 25(OH)D as the outcome variable. Visual inspection of the residual Q-Q plot from the linear regression model of circulating 25(OH)D suggested departure from normality by the residuals. Using the Box-Cox procedure (35), the square-root transformation was chosen. Models with transformed and untransformed results were similar; therefore, for ease of interpretation, only the results from models using the nontransformed 25(OH)D data are presented. A backward stepwise procedure was used, allowing only variables with a P value less than or equal to 0.10 for at least 1 category to remain in the model, while retaining age, sex, cohort, and season. Stepwise procedures were conducted for all cohorts combined, for US-only cohorts, and stratified by sex, race/ethnicity, and season. Overall P values for categorical variables were calculated using the Type III Sum of Squares feature from the Proc GLM procedure in SAS (SAS Institute Inc., Cary, North Carolina). Predictors of “very low” (<25 nmol/L), “low” (25–50 nmol/L), and “higher” (≥75 nmol/L) 25(OH)D concentrations were examined using multivariate polytomous logistic regression. The control group category of 50–<75 nmol/L was chosen to correspond with our site-specific analyses (28). Participants with missing information on diet (n = 258) were excluded from stepwise and polytomous regression models. All statistical analyses were conducted using SAS, version 9.1.3 or 9.2. Figures were created using R (R Foundation for Statistical Computing, Vienna, Austria (http://www.r-project.org/)).

RESULTS

Participating VDPP cohorts and control characteristics are presented in Table 1. All participants were adults; the majority were over age 50 years. In most cohorts, blood samples were collected throughout the year, except CLUE II, in which samples were collected from May to November, and ATBC, in which only 7% of samples were collected during June and August and none were collected in July.
Table 1.

Characteristics (%) of Participants in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, by Cohort

ATBC (n = 842)CLUE II (n = 445)CPS-II (n = 402)HPFS (n = 147)MEC (n = 416)NHS (n = 477)NYU-WHS (n = 472)PLCO (n = 794)SMHS (n = 202)SWHS (n = 526)Total (n = 4,723)
Sex
    Male10035.346.510051.90048.4100045.2
    Female064.753.5048.110010051.6010054.8
Age at blood draw, years
    ≤2900.9000000000.1
    30–3905.200006.60001.1
    40–490.218.202.0015.122.9015.826.29.2
    50–5960.628.31.524.513.941.541.319.520.325.130.8
    60–6939.028.839.132.735.843.429.262.033.248.341.7
    70–790.216.053.240.139.40018.530.70.415.3
    80–8902.76.20.710.8000001.8
Race/ethnicity
    White10099.898.093.912.598.372.292.60072.3
    Black00.20.5024.00.411.13.9004.0
    Asian000.50.726.21.00.43.010010018.4
    Other001.02.037.30.24.40.5004.0
    Missing data0003.40011.90001.3
Country of residence
    United States
    Northeast0020.615.6a056.299.612.60020.0
    Midwest0029.934.7019.3055.20014.8
    West0025.426.510012.80.221.20016.7
    South010024.122.4011.70.211.10015.2
    Finland10000000000017.8
    China0000000010010015.4
Latitude, degrees North
    <350020.925.997.413.40.46.810010029.1
    35–42010052.242.22.656.499.646.50038.9
    >42100026.932.0030.2046.70032.0
Year of blood draw
    1985–198910010000038.496.800040.8
    1990–199400094.61.261.63.214.50012.0
    1995–19990038.65.425.50080.0094.329.6
    2000–20040061.4071.4005.580.25.716.5
    2005 or later00001.900019.801.0
Season of blood draw
    Winter36.9016.715.024.025.826.122.417.321.122.7
    Spring27.233.319.727.927.927.919.728.226.222.826.2
    Summer10.847.041.834.027.924.324.824.218.315.424.9
    Fall25.119.821.923.120.222.029.425.238.140.726.3
25-Hydroxyvitamin D, nmol/L
    <2536.23.84.22.711.35.712.74.218.824.914.4
    25–<37.523.59.08.78.216.312.421.014.929.735.618.5
    37.5–<5016.616.219.221.122.124.523.124.725.221.921.2
    50–<7518.843.643.342.233.439.631.442.720.815.032.3
    75–<1004.220.018.419.712.514.010.010.35.02.710.6
    ≥1000.77.46.26.14.33.81.93.30.503.1

Abbreviations: ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study; CPS-II, Cancer Prevention Study II Nutrition Cohort; HPFS, Health Professionals Follow-Up Study; MEC, Multi-Ethnic Cohort Study; NHS, Nurses’ Health Study; NYU-WHS, New York University Women's Health Study; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.

Percentages do not total 100 for this cohort because of missing data.

Characteristics (%) of Participants in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, by Cohort Abbreviations: ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study; CPS-II, Cancer Prevention Study II Nutrition Cohort; HPFS, Health Professionals Follow-Up Study; MEC, Multi-Ethnic Cohort Study; NHS, Nurses’ Health Study; NYU-WHS, New York University Women's Health Study; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study. Percentages do not total 100 for this cohort because of missing data. Participants came from Finland, Shanghai, China, and all major geographic regions of the United States. Seventy-two percent of participants were white, 4% were black, 18% were Asian, and 4% were of other race/ethnicity. In the ATBC, SMHS, and SWHS cohorts, approximately 20% of the population or more had very low 25(OH)D levels (<25 nmol/L). In the CLUE II, CPS-II, and HPFS cohorts, more than 20% of the population had 25(OH)D concentrations greater than or equal to 75 nmol/L. Figure 1 illustrates the unadjusted distributions of circulating 25(OH)D by country. Vertical lines show cutpoints used in the analyses. The distribution of 25(OH)D concentrations was slightly higher among men in the United States (Figure 1, part A) and China (Figure 1, part B) than among women in these countries. The median 25(OH)D levels among men and women in the United States were 58.4 nmol/L and 51.7 nmol/L, and in China they were 38.0 nmol/L and 33.1 nmol/L, respectively. The ATBC Study, which included only Finnish men, had the lowest vitamin D status of all cohorts (median concentration, 31.9 nmol/L) (Figure 1, part C).
Figure 1.

Distribution of circulating 25-hydroxyvitamin D (25(OH)D) concentrations by country within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. A) Distribution of circulating 25(OH)D concentrations among US men and women. Vertical lines represent a priori cutpoints of 25, 37.5, 50, 75, and 100 nmol/L. 25(OH)D concentrations in men were statistically significantly greater than those in women (P < 0.001). B) Distribution of circulating 25(OH)D concentrations among men and women in Shanghai, China. 25(OH)D concentrations in men were statistically significantly greater than those in women (P < 0.001). C) Distribution of circulating 25(OH)D concentrations among men in Finland.

Distribution of circulating 25-hydroxyvitamin D (25(OH)D) concentrations by country within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. A) Distribution of circulating 25(OH)D concentrations among US men and women. Vertical lines represent a priori cutpoints of 25, 37.5, 50, 75, and 100 nmol/L. 25(OH)D concentrations in men were statistically significantly greater than those in women (P < 0.001). B) Distribution of circulating 25(OH)D concentrations among men and women in Shanghai, China. 25(OH)D concentrations in men were statistically significantly greater than those in women (P < 0.001). C) Distribution of circulating 25(OH)D concentrations among men in Finland. Figure 2 illustrates the distribution of circulating 25(OH)D by race/ethnicity, season of blood draw, and latitude. In whites (Figure 2, part A), 25(OH)D concentrations were lowest in all seasons among persons living at latitudes greater than 42°N and highest among those living at latitudes lower than 35°N. The amplitude of seasonal differences was most marked among whites living in the North, although seasonal differences were statistically significant in each latitude stratum. In blacks (n = 188; Figure 2, part B), mean concentrations did not vary within season by 2 latitude strata, except that those living in the South (<35°N latitude) had borderline-significantly different circulating 25(OH)D according to season (P = 0.06). Among Asians (n = 871) and persons of “other” race/ethnicity (n = 188) (Figure 2, part C), statistically significant differences in circulating 25(OH)D were observed by season; these subgroups could not be examined by latitude because of a lack of geographic diversity.
Figure 2.

Mean circulating 25-hydroxyvitamin D (25(OH)D) concentrations by race/ethnicity, season, and latitude within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Circles represent mean values; bars represent the standard error. A) 25(OH)D concentrations among whites (n = 3,415) across seasons, within latitude categories of <35°N, 35°N–42°N, and >42°N. Differences in mean concentrations were statistically significant for all seasons at each latitude (for winter, spring, and fall, P < 0.001; for summer, P = 0.0082). Seasonal differences within latitude were also statistically significant: for <35°N, P = 0.017; for 35°N–42°N, P < 0.0001; and for >42°N, P < 0.0001. B) 25(OH)D concentrations among blacks (n = 188) across seasons, within latitude categories of <35°N and ≥35°N. Within-season 25(OH)D did not vary by latitude, but the difference within latitude across seasons was borderline-significant for latitude <35°N (P = 0.06), whereas no differences across season were noted for latitude ≥35°N (P = 0.94). C) 25(OH)D concentrations among Asians (n = 871) and persons of “other” race/ethnicity (n = 188) across seasons. The majority of Asians resided between 35°N latitude and 42°N latitude; statistically significant differences in 25(OH)D concentrations were observed across seasons (P < 0.0001). The majority of persons of “other” race/ethnicity resided at <35°N latitude; significant differences were observed by season (P = 0.03).

Mean circulating 25-hydroxyvitamin D (25(OH)D) concentrations by race/ethnicity, season, and latitude within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Circles represent mean values; bars represent the standard error. A) 25(OH)D concentrations among whites (n = 3,415) across seasons, within latitude categories of <35°N, 35°N–42°N, and >42°N. Differences in mean concentrations were statistically significant for all seasons at each latitude (for winter, spring, and fall, P < 0.001; for summer, P = 0.0082). Seasonal differences within latitude were also statistically significant: for <35°N, P = 0.017; for 35°N–42°N, P < 0.0001; and for >42°N, P < 0.0001. B) 25(OH)D concentrations among blacks (n = 188) across seasons, within latitude categories of <35°N and ≥35°N. Within-season 25(OH)D did not vary by latitude, but the difference within latitude across seasons was borderline-significant for latitude <35°N (P = 0.06), whereas no differences across season were noted for latitude ≥35°N (P = 0.94). C) 25(OH)D concentrations among Asians (n = 871) and persons of “other” race/ethnicity (n = 188) across seasons. The majority of Asians resided between 35°N latitude and 42°N latitude; statistically significant differences in 25(OH)D concentrations were observed across seasons (P < 0.0001). The majority of persons of “other” race/ethnicity resided at <35°N latitude; significant differences were observed by season (P = 0.03). Table 2 provides unadjusted summary data for potential correlates analyzed according to a priori 25(OH)D cutpoints. Higher percentages of black and Asian participants had 25(OH)D concentrations less than 25 nmol/L as compared with whites and persons of “other” race/ethnicity. The prevalence of 25(OH)D concentrations less than 25 nmol/L was highest among persons who had had blood drawn in the winter. Circulating 25(OH)D concentrations also varied by alcohol consumption, body mass index, use of hormone replacement therapy, education, history of diabetes, history of hypertension, cigarette smoking, physical activity, and use of nutritional supplements.
Table 2.

Distribution of Participant Characteristics According to A Priori 25-Hydroxyvitamin D Category in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa

No. of ParticipantsMean Serum 25(OH)D, nmol/LSerum 25(OH)D Category, nmol/L
<2525–<37.537.5–<5050–<7575–<100≥100
Mean Value
Age at blood draw, years58.959.761.162.162.061.6
Body mass indexb26.226.226.425.825.224.5
Vitamin D intake, IU/day139164204219242239
Dietary calcium intake, mg/day9328909389661,011965
Milk intake, g/day323237254265278293
Fish intake, g/day32
34
34
32
30
30
Row %
Sex
    Male2,13549.218172032103
    Female2,58850.412202233113
Race/ethnicity
    White3,41552.613152136124
    Black18841.12726191953
    Asian87141.12031232151
    Other18851.78182238112
Education
    Less than high school1,01041.62425212452
    Completion of high school85251.711202133123
    Vocational school54541.82423212362
    Some college1,10452.212172036123
    College graduation51756.57112439144
    Graduate study61758.95112242165
Season of blood draw
    Fall1,24048.814202232102
    Winter1,07040.82623212361
    Spring1,23648.515212130103
    Summer1,17560.74102043167
Body mass index category
    <252,17851.414182032124
    25–<301,79949.614182233103
    ≥3071745.616
21
24
29
8
1
Row %
Physical activity
    Sedentary1,54844.22023222681
    Light activity1,19049.115172234103
    Moderate activity78352.49182237113
    Vigorous activity93556.010151935156
History of diabetes
    No4,35250.214182132113
    Yes27744.01629202952
History of hypertension
    No3,30850.215182033113
    Yes1,35749.11319243293
Hormone replacement therapy (women only)
    No current use2,01849.713212231113
    Current use46956.25142340134
Smoking status
    Never smoker2,01651.012192233123
    Former smoker1,38057.25132341145
    Current smoker1,24539.62924182252
Alcohol use
    No current use1,93847.11622222993
    Current use2,47051.913162135123
Supplemental calcium use
    No current use2,80149.516182032103
    Current use79358.16102340164
Multivitamin use
    No current use2,46849.912202332103
    Current use1,08959.54112042175
Dietary vitamin D intake, quintile of IU/day
    Quintile 175340.82418182883
    Quintile 275347.014181935113
    Quintile 375250.211162236113
    Quintile 475353.49152236144
    Quintile 575257.75112240174

Abbreviation: 25(OH)D, 25-hydroxyvitamin D.

Summary statistics shown are unadjusted.

Weight (kg)/height (m)2.

Distribution of Participant Characteristics According to A Priori 25-Hydroxyvitamin D Category in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa Abbreviation: 25(OH)D, 25-hydroxyvitamin D. Summary statistics shown are unadjusted. Weight (kg)/height (m)2. Results from the stepwise regression models are presented in Table 3. Variables positively associated with circulating 25(OH)D concentrations among all controls were male sex, summer blood draw (vs. fall), vigorous physical activity (vs. light activity), current alcohol use (vs. none), vitamin D intake, fish intake, and current use of calcium and multivitamin supplements (vs. no current use). Variables associated with lower circulating 25(OH)D were body mass index, winter and spring blood draw (vs. fall), history of diabetes, sedentary physical activity (vs. light activity), current smoking (vs. never smoking), and black and “other” race/ethnicity (vs. white). Together, these variables explained 30% of the variation in 25(OH)D concentrations. Models limited to US-only participants yielded similar findings, except that intake of milk (which is fortified with vitamin D in the United States) was a predictor while fish intake was not (data not shown).
Table 3.

Variables Associated With Circulating 25-Hydroxyvitamin D Concentrations (nmol/L) Among Controls in Stepwise Regression Models, Overall and by Sex and Race/Ethnicity, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa

Total
Sex
Race/Ethnicity
Male
Female
White
Black
Asian
βP ValueβP ValueβP ValueβP ValueβP ValueβP Value
No. of controls4,4652,0232,4493,203181867
Adjusted r20.300.360.260.290.230.31
Male sex (vs. female)7.85<0.0018.20<0.00114.70<0.0019.010.01
Race/ethnicity<0.0001b0.0001b<0.0001b
    White (referent)
    Other−6.080.004−7.150.04−4.740.08
    Black−13.53<0.001−11.000.001−14.86<0.001
    Asian−0.450.8374.370.18−5.120.10
Season of blood draw<0.0001b<0.0001b<0.0001b<0.0001b0.26b<0.0001b
    Fall (referent)
    Winter−7.13<0.001−7.89<0.001−6.31<0.001−7.54<0.0014.270.40−8.73<0.001
    Spring−2.180.010−2.450.05−1.980.08−1.900.075.600.24−3.960.01
    Summer6.80<0.0018.72<0.0016.02<0.0016.88<0.0019.380.0488.52<0.001
Body mass indexc
    Continuous−0.54<0.001−0.74<0.001
    Categorical0.07b<0.0001b
    <25 (referent)
    25–<30−0.430.67−2.370.004
    ≥30−2.960.04−7.02<0.001
Physical activity<0.0001b0.002b<0.0001b
    Sedentary−1.490.08−1.830.11−1.230.20
    Light activity (referent)
    Moderate activity0.500.620.150.930.590.62
    Vigorous activity3.37<0.0013.990.015.07<0.001
History of diabetes (yes vs. no)−3.670.005−3.200.07−4.140.04−5.290.003
Smoking status0.02b0.001b0.03b0.03b
    Never smoker (referent)
    Former smoker0.050.950.830.410.750.42−2.700.24
    Current smoker−3.630.003−5.32<0.001−3.760.02−5.310.01
Current alcohol use (vs. no current use)2.460.0013.230.011.910.062.430.013.720.07
Dietary calcium intake (per 100 mg)−0.30.011.90.003−0.70.04
Dietary vitamin D intake (per 100 IU)1.8<0.0013.5<0.0011.8<0.001−3.10.01
Milk intake (per cup (237 mL))2.16<0.001
Fish intake (per ounce (28.4 g))0.780.020.930.03
Current use of calcium supplements (vs. no current use)4.88<0.0014.93<0.0015.87<0.0015.71<0.001
Current use of multivitamins (vs. no current use)3.65<0.0015.69<0.0013.67<0.00117.56<0.001

Results were adjusted for age, and cohort.

P value for categorical variable.

Weight (kg)/height (m)2.

Variables Associated With Circulating 25-Hydroxyvitamin D Concentrations (nmol/L) Among Controls in Stepwise Regression Models, Overall and by Sex and Race/Ethnicity, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa Results were adjusted for age, and cohort. P value for categorical variable. Weight (kg)/height (m)2. Results from stepwise regression models stratified by sex and race/ethnicity are also shown in Table 3. Predictors in men and women varied slightly: Only the category of obesity (body mass index ≥30) was associated with significantly lower concentrations in men; a linear association with body mass index was observed among women. Associations with physical activity, smoking, vitamin use, and dietary sources varied between the sexes. In whites, who comprised 72% of the total sample population, statistically significant predictors were the same as those for the entire population. Among blacks, only male sex, summer blood draw, dietary calcium intake, and current multivitamin use remained in the model; all were positively associated with circulating 25(OH)D. Among Asians, male sex, summer blood draw, and current alcohol use were positively associated with 25(OH)D concentrations, while winter and spring blood draw (vs. fall), current smoking, and dietary calcium and vitamin D intakes were inversely related. Table 4 presents results from stepwise regression analyses stratified by season of blood draw. Male sex and dietary vitamin D intake were positively associated and body mass index and black race/ethnicity were inversely associated with 25(OH)D concentrations in every season. The adjusted r2 value for winter was 32%, whereas the summer model explained only 16% of the variation in 25(OH)D concentrations. In the winter, as opposed to the summer (when sun exposure would be expected to dominate 25(OH)D status), cigarette smoking and a high school education were inversely associated with circulating 25(OH)D concentrations and fish intake and multivitamin use were positively associated.
Table 4.

Variables Associated With Circulating 25-Hydroxyvitamin D Concentrations (nmol/L) Among Controls in Stepwise Regression Models According to Season of Blood Draw, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa

Season of Blood Draw
Winter
Spring
Summer
Fall
βP ValueβP ValueβP ValueβP Value
No. of controls1,0151,1781,0961,188
Adjusted r20.320.280.160.25
Male sex (vs. female)5.720.016.93<0.0018.98<0.0014.040.046
Race/ethnicity0.03b<0.001b<0.001b<0.001b
    White (referent)
    Other−5.850.14−5.350.17−11.510.013.920.38
    Black−11.120.003−9.230.01−15.21<0.001−16.93<0.001
    Asian−3.060.468.960.05−6.030.153.200.49
Education0.13b
    Less than high school−3.350.21
    Completion of high school−4.820.05
    Vocational school−4.380.11
    Some college−0.550.81
    College graduation−2.890.27
    Graduate study (referent)
Body mass indexc
    Continuous−0.63<0.001−0.74<0.001
    Categorical0.002b0.002b
    <25 (referent)
    25–<30−2.130.11−1.000.44
    ≥30−6.80<0.001−7.13<0.001
History of diabetes (yes vs. no)−5.300.04−5.080.10−5.510.02
Smoking status0.26b0.02b0.002b
    Never smoker (referent)
    Former smoker−0.570.720.590.700.470.77
    Current smoker−4.990.047−5.950.01−8.56<0.001
Current alcohol use (vs. no current use)2.650.063.860.023.310.03
Dietary vitamin D intake (per 100 IU)2.3<0.0012.2<0.0012.0<0.0011.20.03
Fish intake (per ounce (28.4 g))2.010.002
Current use of multivitamins (vs. no current use)5.030.0037.38<0.0015.760.01

Results were additionally adjusted for age and cohort.

P value for categorical variable.

Weight (kg)/height (m)2.

Variables Associated With Circulating 25-Hydroxyvitamin D Concentrations (nmol/L) Among Controls in Stepwise Regression Models According to Season of Blood Draw, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa Results were additionally adjusted for age and cohort. P value for categorical variable. Weight (kg)/height (m)2. In the subset of 4 cohorts with data on dose of supplemental vitamin D and calcium (ATBC, CPS-II, NHS, and PLCO), both total vitamin D intake (12.7-nmol increase/1,000 IU) and fish intake (6.1-nmol/L increase per 100 g) remained in the model. The Spearman correlation between 25(OH)D and dietary vitamin D intake (all cohorts) was 0.22 (P < 0.0001), and for total vitamin D intake (4 cohorts) it was 0.29 (P < 0.0001). In the 5 cohorts with information on hair color and eye color (ATBC, HPFS, MEC, SMHS, and SWHS), these variables did not remain in the final model, and race/ethnicity remained a statistically significant predictor. Table 5 displays predictors of 25(OH)D concentrations for the categories <25, 25–<50, and ≥75 nmol/L. The statistically significant predictors of very low 25(OH)D concentrations (<25 nmol/L) were black race/ethnicity, low vitamin D intake, female sex, obesity, sedentary behavior, and winter blood draw. Factors inversely associated with very low concentrations of 25(OH)D included Asian race/ethnicity, calcium supplement use, multivitamin use, and alcohol consumption. Predictors of 25(OH)D concentrations between 25 nmol/L and 49.9 nmol/L were similar to those for <25 nmol/L, but the associations were weaker. Vigorous physical activity was positively associated with higher 25(OH)D concentrations (≥75 nmol/L), while obesity and low dietary vitamin D intake were inversely associated. Current use of calcium and multivitamin supplements, male sex, and summer blood draw were associated with a borderline-significantly higher likelihood of greater 25(OH)D concentrations.
Table 5.

Odds Ratios for the Association Between Selected Covariates and Circulating 25-Hydroxyvitamin D Concentrations, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa

Serum 25-Hydroxyvitamin D Categoryb, nmol/L
<25
25–<50
≥75
OR95% CIOR95% CIOR95 CI
Sex
    Male1.00Referent1.00Referent1.00Referent
    Female4.152.57, 6.701.701.36, 2.120.790.61, 1.03
Race/ethnicity
    White1.00Referent1.00Referent1.00Referent
    Black9.174.90, 17.182.531.60, 4.000.830.42, 1.64
    Asian0.250.07, 0.940.970.59, 1.590.740.40, 1.36
    Other1.000.44, 2.271.100.69, 1.770.510.27, 0.96
Season of blood draw
    Fall1.00Referent1.00Referent1.00Referent
    Winter3.232.43, 4.301.661.34, 2.060.830.60, 1.15
    Spring1.621.22, 2.141.231.01, 1.501.040.80, 1.37
    Summer0.310.21, 0.460.650.54, 0.801.220.95, 1.56
Body mass indexc category
    <251.00Referent1.00Referent1.00Referent
    25–<301.040.83, 1.321.100.94, 1.300.780.63, 0.95
    ≥301.821.32, 2.501.601.29, 1.990.580.42, 0.80
Physical activity
    Sedentary1.491.12, 1.981.160.95, 1.421.070.80, 1.41
    Light activity1.00Referent1.00Referent1.00Referent
    Moderate activity0.900.61, 1.310.950.76, 1.191.010.74, 1.36
    Vigorous activity1.120.79, 1.610.850.68, 1.061.611.23, 2.12
Alcohol use
    No current use1.00Referent1.00Referent1.00Referent
    Current use0.610.46, 0.800.900.75, 1.071.070.86, 1.34
Dietary vitamin D intake, quintile of IU/day
    Quintile 14.673.12, 7.001.631.24, 2.140.630.43, 0.92
    Quintile 23.282.23, 4.841.351.05, 1.730.700.51, 0.96
    Quintile 32.121.43, 3.161.301.02, 1.650.710.52, 0.95
    Quintile 41.400.93, 2.121.271.01, 1.610.740.56, 0.99
    Quintile 51.00Referent1.00Referent1.00Referent
Supplemental calcium use
    No current use1.00Referent1.00Referent1.00Referent
    Current use0.380.26, 0.560.760.61, 0.941.311.01, 1.70
Multivitamin use
    No current use1.00Referent1.00Referent1.00Referent
    Current use0.470.31, 0.700.710.58, 0.861.190.94, 1.50

Abbreviations: CI, confidence interval; OR, odds ratio.

Results from a polytomous logistic regression model with mutual adjustment for the variables shown. Results were additionally adjusted for age and cohort.

Reference category: 50–<75 nmol/L.

Weight (kg)/height (m)2.

Odds Ratios for the Association Between Selected Covariates and Circulating 25-Hydroxyvitamin D Concentrations, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa Abbreviations: CI, confidence interval; OR, odds ratio. Results from a polytomous logistic regression model with mutual adjustment for the variables shown. Results were additionally adjusted for age and cohort. Reference category: 50–<75 nmol/L. Weight (kg)/height (m)2.

DISCUSSION

In this analysis of over 4,700 men and women, low concentrations of 25(OH)D were common, especially in China and Finland. Marked variation in 25(OH)D concentrations by season of blood draw was seen among whites, especially for those living in northern latitudes, whereas less striking seasonal variation was observed in blacks and persons of “other” race/ethnicity. Variables that significantly predicted circulating 25(OH)D concentrations included sex, race/ethnicity, body mass index, alcohol consumption, fish intake, dietary vitamin D intake, season of blood draw, history of diabetes, physical activity, smoking status, and use of vitamin D-containing multivitamins and calcium supplements. Participants with higher 25(OH)D concentrations (≥75 nmol/L) tended to be male, to be leaner, to consume more dietary vitamin D, and to engage in vigorous physical activity. The prevalence of very low concentrations of 25(OH)D (<25 nmol/L) in most US cohorts in this analysis was similar to national estimates of approximately 4% in older adults (36). Exceptions included the MEC, which has large proportions of African Americans and Japanese Americans, and NYU-WHS, which includes only women living at a higher latitude and in a city (New York) where ultraviolet light exposure may be further limited by tall buildings that block sunlight. The prevalence of 25(OH)D concentrations less than 25 nmol/L was 11% in MEC and 13% in NYU-WHS. Prevalences of low concentrations were higher in Finland and China than in the United States. In Finland, a country at a high northern latitude, 64% of blood samples were collected in months during which ultraviolet-induced vitamin D synthesis in the skin is very limited. By contrast, Asians living at a lower latitude in Shanghai probably absorb less ultraviolet radiation because of their somewhat darker skin pigmentation and possibly cultural practices such as avoiding direct sun exposure and wearing more clothing. In both Finland and China, food is not regularly fortified with vitamin D, in contrast to the United States. The inclusion of the MEC cohort points out interesting contrasts between Asian populations in the United States and China and the potential influence of location. For example, very few persons of Japanese ancestry in the MEC (1 out of 109) had concentrations less than 25 nmol/L, which explains the lower risk of very low 25(OH)D concentrations among “Asians” after we controlled for cohort (e.g., the SWHS and SMHS) in the model. Japanese Americans in the MEC cohort are exposed to more sunlight than Chinese persons in Shanghai, and they also consume milk fortified with vitamin D. The concentration of 25(OH)D that is optimal for disease prevention is still undetermined, but concentrations of 75 nmol/L or more have been advocated (34, 37). A relatively small proportion of participants had concentrations greater than 75 nmol/L, ranging from 3% in SWHS to 27% in CLUE II, with the latter cohort having had their blood samples collected between May and November. The strongest predictor of very low 25(OH)D concentrations in the present study was race/ethnicity, with blacks being 9 times more likely than whites to have very low vitamin D status, which is consistent with the literature (6, 7, 10, 16–18, 27). This finding is probably due in part to the higher melanin content of dark skin, which blocks pro-vitamin D3 formation in the epidermis and dermis (38). Current multivitamin use was a particularly strong predictor of circulating 25(OH)D among blacks, providing a modifiable target for reducing vitamin D deficiency in that population. Body mass index was an inverse correlate of circulating 25(OH)D in the entire population, which is consistent with previous reports (27, 39). Whether this is due to differences in sun exposure among persons with different body mass indices, increased clearance by a larger body-fat pool, negative feedback from higher circulating 1,25-dihydroxyvitamin D, or sequestration in fat is uncertain (40, 41). Body mass index was not a correlate of 25(OH)D among blacks and Asians in our sample, which is consistent with recent studies (18, 23, 42). Differences in dermal production and sequestration by body fat may provide one explanation (40), but more research on these complex relations is needed. Dietary vitamin D intake and use of vitamin D-containing multivitamin supplements were strong positive predictors of 25(OH)D concentrations in most subgroups studied, which is consistent with previous studies of vitamin D intake and supplementation (27, 43–45). Calcium supplements often contain vitamin D, which probably explains the positive association between calcium intake and circulating 25(OH)D levels, although calcium may also spare conversion of 25(OH)D to 1,25-dihydroxyvitamin D (46). One exception was observed for Asians, among whom calcium and vitamin D intake were inversely related to 25(OH)D levels, for reasons that are unclear. This association may have been driven by different factors among Asians living in China, where supplement use is uncommon and milk is not fortified with vitamin D. Although they were statistically significant predictors, dietary vitamin D intake and total vitamin D intake were relatively weak correlates of circulating 25(OH)D. Male sex was associated with higher circulating 25(OH)D in the stepwise models and in polytomous regression models, which is consistent with most previous reports (27). This may be due to women's higher percentage of body fat (beyond that measured through body mass index) (15), differences in amount of time spent outdoors, or sun protection behaviors (47). Other correlates of circulating 25(OH)D concentrations observed in this study have been inconsistently associated with blood 25(OH)D concentrations in the literature. The association of alcohol intake with higher vitamin D concentrations that we observed in this study has not been seen consistently in other reports. In 1 study of elderly Americans, Jacques et al. (11) observed statistically significantly higher 25(OH)D concentrations with greater alcohol intake, but in another study of participants aged 49–75 years in which results were controlled for education and employment status, Egan et al. (6) did not. Current smoking was associated with lower circulating 25(OH)D concentrations in comparison with never smoking, which is consistent with some (2, 6, 13) but not other (10, 11, 15, 48) studies. However, no dose-response association was observed by number of cigarettes smoked per day, and smoking did not remain in the polytomous regression models. Higher 25(OH)D concentrations were observed among persons reporting vigorous physical activity, driven primarily by associations in whites and males. A statistically significant positive association between greater physical activity and 25(OH)D concentrations was observed in only 3 (7, 17, 23) out of 7 (7, 8, 10, 11, 13, 17, 23) studies. Associations with physical activity may be a surrogate for greater sun exposure during outdoor physical activity (25, 49). Finally, a history of diabetes was associated with a significantly lower 25(OH)D concentration, even after controlling for body mass index. Two systematic reviews and meta-analyses have also shown an inverse association between vitamin D status or intake and type 2 diabetes or metabolic syndrome (50, 51), although many of the contributing studies, as in this study, were cross-sectional. This interesting finding merits further investigation. Strengths of this study include the large sample size and the racial and geographic variability of the population. In addition, all assays were performed in a single laboratory using the same method for all assays within a period of 2–3 months. However, only 4% of the sample was black; thus, more research in this at-risk group is needed. One limitation was that few investigators had collected detailed information on sun exposure, use of sunscreen or protective clothing, skin tone, or sun sensitivity, which probably accounts for a considerable proportion of the unexplained variation (i.e., ∼70%) in 25(OH)D concentrations. However, race/ethnicity, physical activity, and season of blood draw served as proxies for skin tone and sun exposure to some degree. Additional research on other sources of interindividual variability, including genetic factors (52), is needed. For pooling of the data across cohorts, the level of detail for each variable was dictated by the cohort with the least detailed information, prohibiting finer examination of some variables, such as total vitamin D intake. Although we were unable to examine the association with individual vitamin D supplements, their use was uncommon (31). We examined correlates of 25(OH)D using a cross-sectional study design. The extent to which modification of these variables would lead to changes in 25(OH)D is uncertain. In general, participants in cohort studies are more educated and of higher socioeconomic status than members of the general population; thus, results from this study are generalizable to similar populations. Even in this large pooled study of data from 10 cohorts, relatively few persons had very high concentrations of vitamin D, limiting investigation of correlates of high concentrations. Understanding the correlates of vitamin D status has clinical, research, and public health applications. This information can help clinicians identify persons most at risk for vitamin D deficiency, who can then be screened and treated if necessary. As Table 4 shows, blacks, females, the obese, persons with low vitamin D intake, persons who are physically inactive, and persons who are not taking supplemental calcium or multivitamins are much more likely to have very low concentrations of 25(OH)D. Clinicians checking vitamin D concentrations during the winter or spring (e.g., January–June) will be less likely to overlook insufficient or deficient 25(OH)D concentrations. These same risk factors can also be used to select at-risk individuals for clinical trials, and knowledge of correlates of circulating 25(OH)D also aids in the analysis and interpretation of observational study results. The markedly higher prevalence of very low 25(OH)D concentrations in blacks as compared with whites and among persons living in northern latitudes during less sunny months supports concern about vitamin D status in these populations and its possible impact on health outcomes.
  50 in total

1.  Sun protective behaviors and sunburn experiences in parents of youth ages 11 to 18.

Authors:  Cheryll J Cardinez; Vilma E Cokkinides; Martin A Weinstock; Mary C O'Connell
Journal:  Prev Med       Date:  2004-11-26       Impact factor: 4.018

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors.

Authors:  M Z Erkal; J Wilde; Y Bilgin; A Akinci; E Demir; R H Bödeker; M Mann; R G Bretzel; H Stracke; M F Holick
Journal:  Osteoporos Int       Date:  2006-05-23       Impact factor: 4.507

4.  Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter.

Authors:  Ann Burgaz; Agneta Akesson; Annette Oster; Karl Michaëlsson; Alicja Wolk
Journal:  Am J Clin Nutr       Date:  2007-11       Impact factor: 7.045

5.  Association of race, body fat and season with vitamin D status among young women: a cross-sectional study.

Authors:  Kevin McKinney; Carmen Radecki Breitkopf; Abbey B Berenson
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-10       Impact factor: 3.478

6.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Shanna Nesby-O'Dell; Kelley S Scanlon; Mary E Cogswell; Cathleen Gillespie; Bruce W Hollis; Anne C Looker; Chris Allen; Cindy Doughertly; Elaine W Gunter; Barbara A Bowman
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

7.  Vitamin D status and its determinants in adolescents from the Northern Ireland Young Hearts 2000 cohort.

Authors:  Tom R Hill; Alice A Cotter; Sarah Mitchell; Colin A Boreham; Werner Dubitzky; Liam Murray; J J Strain; Albert Flynn; Paula J Robson; Julie M W Wallace; Mairead Kiely; Kevin D Cashman
Journal:  Br J Nutr       Date:  2008-01-15       Impact factor: 3.718

8.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004.

Authors:  Anne C Looker; Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

9.  Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study.

Authors:  Rob M van Dam; Marieke B Snijder; Jacqueline M Dekker; Coen D A Stehouwer; Lex M Bouter; Robert J Heine; Paul Lips
Journal:  Am J Clin Nutr       Date:  2007-03       Impact factor: 7.045

Review 10.  Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis.

Authors:  Johanna Parker; Omar Hashmi; David Dutton; Angelique Mavrodaris; Saverio Stranges; Ngianga-Bakwin Kandala; Aileen Clarke; Oscar H Franco
Journal:  Maturitas       Date:  2009-12-23       Impact factor: 4.342

View more
  68 in total

1.  Prospective study of ultraviolet radiation exposure and risk of cancer in the United States.

Authors:  Shih-Wen Lin; David C Wheeler; Yikyung Park; Elizabeth K Cahoon; Albert R Hollenbeck; D Michal Freedman; Christian C Abnet
Journal:  Int J Cancer       Date:  2012-05-29       Impact factor: 7.396

2.  25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.

Authors:  Rowan T Chlebowski; Karen C Johnson; Dorothy Lane; Mary Pettinger; Charles L Kooperberg; Jean Wactawski-Wende; Tom Rohan; Mary Jo O'Sullivan; Shagufta Yasmeen; Robert A Hiatt; James M Shikany; Mara Vitolins; Janu Khandekar; F Allan Hubbell
Journal:  Maturitas       Date:  2010-11-18       Impact factor: 4.342

3.  Prospective study of ultraviolet radiation exposure and mortality risk in the United States.

Authors:  Shih-Wen Lin; David C Wheeler; Yikyung Park; Michael Spriggs; Albert R Hollenbeck; D Michal Freedman; Christian C Abnet
Journal:  Am J Epidemiol       Date:  2013-07-17       Impact factor: 4.897

4.  Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors.

Authors:  Patricia Sheean; Claudia Arroyo; Jennifer Woo; Linda Schiffer; Melinda Stolley
Journal:  J Acad Nutr Diet       Date:  2018-01-02       Impact factor: 4.910

5.  Acute hepatologic and nephrologic effects of calcitriol in Syrian golden hamster (Mesocricetus auratus).

Authors:  Ewa Podgorska; Martyna Sniegocka; Marianna Mycinska; Wojciech Trybus; Ewa Trybus; Anna Kopacz-Bednarska; Olga Wiechec; Martyna Krzykawska-Serda; Martyna Elas; Teodora Krol; Krystyna Urbanska; Andrzej Slominski
Journal:  Acta Biochim Pol       Date:  2018-07-17       Impact factor: 2.149

6.  Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Christian C Abnet; Yu Chen; Wong-Ho Chow; Yu-Tang Gao; Kathy J Helzlsouer; Loïc Le Marchand; Marjorie L McCullough; James M Shikany; Jarmo Virtamo; Stephanie J Weinstein; Yong-Bing Xiang; Kai Yu; Wei Zheng; Demetrius Albanes; Alan A Arslan; David S Campbell; Peter T Campbell; Richard B Hayes; Ronald L Horst; Laurence N Kolonel; Abraham M Y Nomura; Mark P Purdue; Kirk Snyder; Xiao-Ou Shu
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

7.  Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Mark P Purdue; D Michal Freedman; Susan M Gapstur; Kathy J Helzlsouer; Francine Laden; Unhee Lim; Gertraud Maskarinec; Nathaniel Rothman; Xiao-Ou Shu; Victoria L Stevens; Anne Zeleniuch-Jacquotte; Demetrius Albanes; Kimberly Bertrand; Stephanie J Weinstein; Kai Yu; Lonn Irish; Ronald L Horst; Judith Hoffman-Bolton; Edward L Giovannucci; Laurence N Kolonel; Kirk Snyder; Walter Willett; Alan A Arslan; Richard B Hayes; Wei Zheng; Yong-Bing Xiang; Patricia Hartge
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

8.  Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Lisa Gallicchio; Kathy J Helzlsouer; Wong-Ho Chow; D Michal Freedman; Susan E Hankinson; Patricia Hartge; Virginia Hartmuller; Chinonye Harvey; Richard B Hayes; Ronald L Horst; Karen L Koenig; Laurence N Kolonel; Francine Laden; Marjorie L McCullough; Dominick Parisi; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Rachael Z Stolzenberg-Solomon; Shelley S Tworoger; Arti Varanasi; Jarmo Virtamo; Lynne R Wilkens; Yong-Bing Xiang; Kai Yu; Anne Zeleniuch-Jacquotte; Wei Zheng; Christian C Abnet; Demetrius Albanes; Kimberly Bertrand; Stephanie J Weinstein
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

9.  Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Kathy J Helzlsouer
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

10.  Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Anne Zeleniuch-Jacquotte; Lisa Gallicchio; Virginia Hartmuller; Kathy J Helzlsouer; Marjorie L McCullough; V Wendy Setiawan; Xiao-Ou Shu; Stephanie J Weinstein; Jocelyn M Weiss; Alan A Arslan; Immaculata De Vivo; Yu-Tang Gao; Richard B Hayes; Brian E Henderson; Ronald L Horst; Karen L Koenig; Alpa V Patel; Mark P Purdue; Kirk Snyder; Emily Steplowski; Kai Yu; Wei Zheng; Susan E Hankinson
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.